Amylyx Pharmaceuticals, Inc. (AMLX) Gross margin 2022–2024
Amylyx Pharmaceuticals, Inc. (AMLX) gross margin by fiscal year — reported gross profit divided by reported revenue.
93.2%FY2024 · since FY2022: 86.5% → 93.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 93.2% | -0.1 pp |
| FY2023 | 93.3% | +6.8 pp |
| FY2022 | 86.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice